Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments.
S. M. Castenmiller, R. de Groot, A. Guislain, K. Monkhorst, K. J. Hartemink, A. A. F. A. Veenhof, E. F. Smit, J. B. A. G. Haanen, M. C. Wolkers
This study shows that tumor-infiltrating lymphocytes (TILs) can be effectively generated from metastatic NSCLC lesions regardless of location or prior treatments, with 76% showing anti-tumoral activity.
bioRxiv · Jan 28, 2022Cancer Biology